Your Tech Story

Natural Cycles Secures $55M to Revolutionize Birth Control with Innovative App

Natural Cycles Secures $55M to Revolutionize Birth Control with Innovative App

The groundbreaking women’s health startup Natural Cycles announced today the completion of a $55 million Series C fundraising round. The company’s total funding to date has exceeded $95 million thanks to this noteworthy investment, highlighting its leadership position in digital contraception.

Background of the Company

Natural Cycles Secures $55M to Revolutionize Birth Control with Innovative App

Image Source: athletechnews.com

Dr. Elina Berglund along with Dr. Raoul Scherwitzl established Natural Cycles in 2013, which created the first direct-to-consumer contraceptive application. The only digital birth control method approved by regulators in the US (FDA), Europe (TÜV SÜD), Canada (Health Canada), Australia (TGA), Singapore (HSA), and South Korea (MFDS) is this cutting-edge app, which has been used by over three million women globally.

Latest Advancements

Natural Cycles recently increased the range of services it offers with the introduction of NC° Postpartum, an app feature that helps new moms heal both mentally and physically after giving birth. Together with NC° Plan Pregnancy, NC° Follow Pregnancy, and NC° Birth Control, NC° Postpartum completes the app’s three modes, offering complete assistance to women at every stage of their reproductive journeys.

Finances and Upcoming Initiatives

Lauxera Capital Partners spearheaded a $55 million fundraising round, in which Point72 Private Investments and J.P. Morgan provided a revolving lending facility. Lauxera Capital Partners’ founding partner Samuel Levy was enthusiastic about the partnership:

"Our mission at Lauxera is to partner with ambitious entrepreneurs to transform the future of medicine with unique technology. The visionary Natural Cycles team has built an exceptional company delivering profitable growth supported by unique clinical and regulatory business moats. We are delighted to partner with Elina, Raoul, and their team to offer women an alternative to traditional approaches without the side effects and compromises."

tech.eu

As part of the transaction, Levy will become a member of the Natural Cycles Board of Directors. The recently obtained money will be put to use creating new goods, speeding up commercial endeavours, and automating the processes involved in healthcare reimbursement.

Goals and Objectives

Natural Cycles’ co-founder and CEO, Dr Raoul Scherwitzl, emphasised the organisation’s dedication to improving women’s health:

“We look forward to leveraging their expertise to fulfil Natural Cycles’ mission of making hormone-free birth control more accessible and combining technology and science to fill the gaps in underserved areas of women’s health.”

tech.eu

In summary, Natural Cycles is in a strong position to increase its influence on women’s health around the world following the successful close of the Series C funding round. The company supports women at every stage of their reproductive journey by providing new, hormone-free contraceptive products that continue to be valuable alternatives to traditional birth control techniques.

Leave a Comment

Your email address will not be published. Required fields are marked *